An Official American Thoracic Society/American College of Chest Physicians Policy statement: The choosing wisely top five list in adult pulmonary medicine

Chest

Volumn 145, Issue 6, 2014, Pages 1383-1391

  Wiener, Renda Soylemez ^a,b,c   Ouellette, Daniel R ^d   Diamond, Edward ^e   Fan, Vincent S ^f,g   Maurer, Janet R ^h,i   Mularski, Richard A ^j,k,l   Peters, Jay I ^b,m   Halpern, Scott D ⁿ  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^d HENRY FORD HEALTH SYSTEM   (United States)

^e Suburban Lung Associates   (United States)

^f VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

ⁱ Quality Improvement and Compliance National Imaging Associates Magellan Health Services Inc   (United States)

^j CENTER FOR HEALTH RESEARCH   (United States)

^k Northwest Permanente PC ^*  (United States)

^l OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^m UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

ⁿ UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMERICAN COLLEGE OF CHEST PHYSICIAN; AMERICAN THORACIC SOCIETY; ARTICLE; CONTROLLED STUDY; GENERAL PRACTICE; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HUMAN; MEDICAL EDUCATION; MEDICAL SOCIETY; ORGANIZATIONAL DOWNSIZING; ORGANIZATIONAL EFFICIENCY; PATIENT ASSESSMENT; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; PROFESSIONAL KNOWLEDGE; PUBLIC-PRIVATE PARTNERSHIP; PULMONOLOGY; RESPIRATORY CARE PRACTICE; TOTAL QUALITY MANAGEMENT;

ANGIOGRAPHY; DIAGNOSTIC TECHNIQUES, RESPIRATORY SYSTEM; EARLY DETECTION OF CANCER; HEALTH CARE COSTS; HUMANS; HYPERTENSION, PULMONARY; LUNG NEOPLASMS; MULTIPLE PULMONARY NODULES; OXYGEN INHALATION THERAPY; PATIENT CARE; PULMONARY EMBOLISM; PULMONARY MEDICINE; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES; VASOCONSTRICTOR AGENTS;

EID: 84901854377     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-0670     Document Type: Article

References (81)

1. Health expenditure, total (% of GDP). The World Bank website. http://data.worldbank.org/indicator/SH.XPD.TOTL.ZS. Accessed January 5, 2014.
2. Enthoven AC. Shattuck lecture - cutting cost without cutting the quality of care. N Engl J Med. 1978;298(22):1229-1238. (Pubitemid 8357641)
3. Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL. The implications of regional variations in Medicare spending. Part 2: health outcomes and satisfaction with care. Ann Intern Med. 2003;138(4):288-298. (Pubitemid 36205925)
4. Grady D, Redberg RF. Less is more: how less health care can result in better health. Arch Intern Med. 2010;170(9):749-750.
5. Medical Professionalism Project. Medical professionalism in the new millennium: a physicians' charter. Lancet. 2002;359(9305):520-522.
6. Allan GM, Lexchin J. Physician awareness of diagnostic and nondrug therapeutic costs: a systematic review. Int J Technol Assess Health Care. 2008;24(2):158-165. (Pubitemid 351519514)
7. Allan GM, Lexchin J, Wiebe N. Physician awareness of drug cost: a systematic review. PLoS Med. 2007;4(9):e283.
8. Brody H. Medicine's ethical responsibility for health care reform - the Top Five list. N Engl J Med. 2010;362(4):283-285.
9. Cassel CK, Guest JA. Choosing wisely: helping physicians and patients make smart decisions about their care. JAMA. 2012;307(17):1801-1802.
10. American Board of Internal Medicine. Choosing Wisely: an initiative of the ABIM foundation. ABIM Foundation website. http://www.choosingwisely.org/. Accessed January 5, 2014.
11. Wahidi MM, Govert JA, Goudar RK, Gould MK, McCrory DC, American College of Chest Physicians. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3-suppl):94S-107S.
12. MacMahon H, Austin JH, Gamsu G, et al Fleischner Society. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology. 2005;237(2):395-400. (Pubitemid 41507873)
13. Gould MK, Donington J, Lynch WR, et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143 (5- suppl):e93S-e120S.
14. Smith-Bindman R, Miglioretti DL, Johnson E, et al. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA. 2012;307(22):2400-2409.
15. Wiener RS, Gould MK, Woloshin S, Schwartz LM, Clark JA. 'The thing is not knowing': patients' perspectives on surveillance of an indeterminate pulmonary nodule [published online ahead of print December 16, 2012]. Health Expect. doi:10.1111/hex.12036.
16. Slatore CG, Press N, Au DH, Curtis JR, Wiener RS, Ganzini L. What the heck is a "nodule"? A qualitative study of veterans with pulmonary nodules. Ann Am Thorac Soc. 2013;10(4):330-335.
17. Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med. 2003;348(25):2535-2542. (Pubitemid 36712195)
18. National Lung Screening Trial Research Team; Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395-409.
19. Wiener RS, Gould MK, Slatore C, Fincke BG, Schwartz LM, Woloshin S. Resource use and guideline concordance in evaluation of pulmonary nodules for cancer: too much and too little care [published online ahead of print April 7, 2014]. JAMA Intern Med. doi:10.1001/jamainternmed.2014.561.
20. Covey AM, Gandhi R, Brody LA, Getrajdman G, Thaler HT, Brown KT. Factors associated with pneumothorax and pneumothorax requiring treatment after percutaneous lung biopsy in 443 consecutive patients. J Vasc Interv Radiol. 2004;15(5):479-483. (Pubitemid 38590872)
21. Dunnick NR, Applegate KE, Arenson RL. The inappropriate use of imaging studies: a report of the 2004 Intersociety Conference. J Am Coll Radiol. 2005;2(5):401-406. (Pubitemid 40725694)
22. Galiè N, Manes A, Negro L, Palazzini M, Bacchi-Reggiani ML, Branzi A. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. Eur Heart J. 2009;30(4):394-403.
23. Lewis GD, Lachmann J, Camuso J, et al. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation. 2007;115(1):59-66. (Pubitemid 46058612)
24. Lewis GD, Shah R, Shahzad K, et al. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation. 2007;116(14):1555-1562. (Pubitemid 47511419)
25. Guazzi M, Vicenzi M, Arena R, Guazzi MD. PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study. Circ Heart Fail. 2011;4(1):8-17.
26. Redfield MM, Chen HH, Borlaug BA, et al RELAX Trial. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA. 2013;309(12):1268-1277.
27. Califf RM, Adams KF, McKenna WJ, et al. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J. 1997;134(1):44-54. (Pubitemid 27329022)
28. Ghofrani HA, Wiedemann R, Rose F, et al. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet. 2002;360(9337):895-900. (Pubitemid 35283832)
29. Blanco I, Gimeno E, Munoz PA, et al. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am J Respir Crit Care Med. 2010;181(3):270-278.
30. Stolz D, Rasch H, Linka A, et al. A randomised, controlled trial of bosentan in severe COPD. Eur Respir J. 2008;32(3):619-628.
31. Galiè N, Hoeper MM, Humbert M, et al ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) [published correction appears in Eur Heart J. 201;32(8):926]. Eur Heart J. 2009;30(20):2493-2537.
32. McLaughlin VV, Archer SL, Badesch DB, et al American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic ociety, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009;53(17):1573-1619.
33. Chaouat A, Bugnet AS, Kadaoui N, et al. Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172(2):189-194. (Pubitemid 40981192)
34. Badesch DB, Champion HC, Sanchez MA, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54(suppl 1):S55-S66.
35. Hoeper MM, Barberà JA, Channick RN, et al. Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol. 2009;54(suppl 1):S85-S96.
36. Hyduk A, Croft JB, Ayala C, Zheng K, Zheng ZJ, Mensah GA. Pulmonary hypertension surveillance-United States, 1980-2002. MMWR Surveill Summ. 2005;54(5):1-28.
37. Guazzi M, Galiè N. Pulmonary hypertension in left heart disease. Eur Respir Rev. 2012;21(126):338-346.
38. Deaño RC, Glassner-Kolmin C, Rubenfire M, et al. Referral of patients with pulmonary hypertension diagnoses to tertiary pulmonary hypertension centers: the multicenter RePHerral study. JAMA Intern Med. 2013;173(10):887-893.
39. Angalakuditi M, Edgell E, Beardsworth A, Buysman E, Bancroft T. Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States. J Media Econ. 2010;13(3):393-402.
40. Berger A, Edelsberg J, Teal S, Mychaskiw MA, Oster G. Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study. BMC Pulm Med. 2012;12:75.
41. Garin MC, Clark L, Chumney EC, Simpson KN, Highland KB. Cost-utility of treatments for pulmonary arterial hypertension: a Markov state-transition decision analysis model. Clin Drug Investig. 2009;29(10):635-646.
42. Highland KB, Strange C, Mazur J, Simpson KN. Treatment of pulmonary arterial hypertension: a preliminary decision analysis. Chest. 2003;124(6):2087-2092. (Pubitemid 38010573)
43. Guyatt GH, Nonoyama M, Lacchetti C, et al. A randomized trial of strategies for assessing eligibility for long-term domiciliary oxygen therapy. Am J Respir Crit Care Med. 2005;172(5):573-580. (Pubitemid 41232968)
44. Chaney JC, Jones K, Grathwohl K, Olivier KN. Implementation of an oxygen therapy clinic to manage users of long-term oxygen therapy. Chest. 2002;122(5):1661-1667. (Pubitemid 35366079)
45. Croxton TL, Bailey WC. Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report. Am J Respir Crit Care Med. 2006;174(4):373-378. (Pubitemid 44223116)
46. O'Driscoll BR, Howard LS, Davison AG; British Thoracic Society. BTS guideline for emergency oxygen use in adult patients. Thorax. 2008;63(suppl 6):vi1-vi68.
47. US Government Accountability Office. Medicare home oxygen: refining payment methodology has potential to lower program and beneficiary spending. Report No. GAO-11-56. GAO website. http://www.gao.gov/products/GAO-11-56. Published 2011. Accessed January 5, 2014.
48. Macnee W. Prescription of oxygen: still problems after all these years. Am J Respir Crit Care Med. 2005;172(5):517-518.
49. Roy PM, Colombet I, Durieux P, Chatellier G, Sors H, Meyer G. Systematic review and meta-analysis of strategies for the diagnosis of suspected pulmonary embolism. BMJ. 2005;331(7511):259.
50. Stein PD, Hull RD, Patel KC, et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med. 2004;140(8):589-602.
51. van Belle A, Büller HR, Huisman MV, et al Christopher Study Investigators. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA. 2006;295(2):172-179. (Pubitemid 43076436)
52. Fesmire FM, Brown MD, Espinosa JA, et al. Critical issues in the evaluation and management of adult patients presenting to the emergency department with suspected pulmonary embolism. Ann Emerg Med. 2011;57:628-652.e675.
53. Qaseem A, Snow V, Barry P, et al Joint American Academy of Family Physicians/American College of Physicians Panel on Deep Venous Thrombosis/Pulmonary Embolism. Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med. 2007;146(6):454-458. (Pubitemid 351650581)
54. Torbicki A, Perrier A, Konstantinides S, et al ESC Committee for Practice Guidelines (CPG). Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2008;29(18):2276-2315.
55. Brockow K, Ring J. Anaphylaxis to radiographic contrast media. Curr Opin Allergy Clin Immunol. 2011;11(4):326-331.
56. Kooiman J, Pasha SM, Zondag W, et al. Meta-analysis: serum creatinine changes following contrast enhanced CT imaging. Eur J Radiol. 2012;81(10):2554-2561.
57. Mitchell AM, Kline JA. Contrast nephropathy following computed tomography angiography of the chest for pulmonary embolism in the emergency department. J Thromb Haemost. 2007;5(1):50-54. (Pubitemid 44921066)
58. Hall WB, Truitt SG, Scheunemann LP, et al. The prevalence of clinically relevant incidental findings on chest computed tomographic angiograms ordered to diagnose pulmonary embolism. Arch Intern Med. 2009;169(21):1961-1965.
59. Le Gal G, Righini M, Parent F, van Strijen M, Couturaud F. Diagnosis and management of subsegmental pulmonary embolism. J Thromb Haemost. 2006;4(4):724-731.
60. Donato AA, Khoche S, Santora J, Wagner B. Clinical outcomes in patients with isolated subsegmental pulmonary emboli diagnosed by multidetector CT pulmonary angiography. Thromb Res. 2010;126(4):e266-e270.
61. Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med. 2011;171(9):831-837.
62. Wiener RS, Schwartz LM, Woloshin S. When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found. BMJ. 2013;347:f3368.
63. Adams DM, Stevens SM, Woller SC, et al. Adherence to PIOPED II investigators' recommendations for computed tomography pulmonary angiography. Am J Med. 2013;126(1):36-42.
64. Penaloza A, Kline J, Verschuren F, et al. European and American suspected and confirmed pulmonary embolism populations: comparison and analysis. J Thromb Haemost. 2012;10(3):375-381.
65. Kovalchik SA, Tammemagi M, Berg CD, et al. Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med. 2013;369(3):245-254.
66. Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143 (5- suppl):e78S-e92S.
67. Jaklitsch MT, Jacobson FL, Austin JH, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg. 2012;144(1):33-38.
68. NCCN clinical practice guidelines in oncology (NCCN guidelines) -lung cancer screening, version 1.2013. National Comprehensive Cancer Network website. http://www.nccn.org/professionals/physician-gls/pdf/lung-screening.pdf. Published 2012. Accessed January 5, 2014.
69. Moyer VA. Screening for lung cancer: US Preventive Services Task Force recommendation statement [published online ahead of print December 31, 2013]. Ann Intern Med. doi:10.7326/M13-2771.
70. Humphrey LL, Deffebach M, Pappas M, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med. 2013;159(6):411-420.
71. Wiener RS, Schwartz LM, Woloshin S, Welch HG. Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records. Ann Intern Med. 2011;155(3):137-144.
72. Tukey MH, Wiener RS. Population-based estimates of transbronchial lung biopsy utilization and complications. Respir Med. 2012;106(11):1559-1565.
73. Veronesi G, Maisonneuve P, Bellomi M, et al. Estimating overdiagnosis in low-dose computed tomography screening for lung cancer: a cohort study. Ann Intern Med. 2012;157(11):776-784.
74. Sone S, Nakayama T, Honda T, et al. Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography. Lung Cancer. 2007;58(3):329-341. (Pubitemid 350051508)
75. Patz EF Jr, Pinsky P, Gatsonis C, et al NLST Overdiagnosis Manuscript Writing Team. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med. 2014;174(2):269-274.
76. Bach P. CT scam: don't believe the hype about lung-cancer screenings. Slate website. http://www.slate.com/articles/health-and-science/medical- examiner/2010/11/ct-scam.html. Published 2010. Accessed January 5, 2014.
77. Levinson W. Physician-patient communication. A key to malpractice prevention. JAMA. 1994;272(20):1619-1620. (Pubitemid 24350718)
78. Levinson W, Roter DL, Mullooly JP, Dull VT, Frankel RM. Physician-patient communication. The relationship with malpractice claims among primary care physicians and surgeons. JAMA. 1997;277(7):553-559. (Pubitemid 27083985)
79. Shapiro RS, Simpson DE, Lawrence SL, Talsky AM, Sobocinski KA, Schiedermayer DL. A survey of sued and nonsued physicians and suing patients. Arch Intern Med. 1989;149(10):2190-2196. (Pubitemid 19258161)
80. Campbell EG, Regan S, Gruen RL, et al. Professionalism in medicine: results of a national survey of physicians. Ann Intern Med. 2007;147(11):795- 802. (Pubitemid 351664442)
81. Kale MS, Bishop TF, Federman AD, Keyhani S. "Top five" lists top $5 billion. Arch Intern Med. 2011;171(20):1856-1858.